Cherry Creek Investment Advisors, Inc. Repligen Corp Transaction History
Cherry Creek Investment Advisors, Inc.
- $196 Million
- Q4 2024
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 2,752 shares of RGEN stock, worth $457,409. This represents 0.2% of its overall portfolio holdings.
Number of Shares
2,752
Previous 2,752
-0.0%
Holding current value
$457,409
Previous $409,000
3.18%
% of portfolio
0.2%
Previous 0.22%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
479Shares Held
54.5MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.26 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.06 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$838 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$270 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$236 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $9.22B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....